Conference Date & Venue
The Grove Hotel
Support Construction of Binaytara's Cancer Hospital in Nepal
Event Description
The Best of Hematology and Breast Cancer™ 2027 in Boise is a premier CME/CE-accredited hematology and oncology conference designed for physicians, advanced practitioners, pharmacists, nurses, and the entire cancer care team. This annual oncology symposium delivers the most up-to-date clinical insights in hematologic malignancies and breast cancer, ensuring participants can translate research into practice.
Building on groundbreaking findings from the 68th American Society of Hematology (ASH26) Annual Meeting and the San Antonio Breast Cancer Symposium (SABCS26), this two-day program provides concise, practice-focused updates. Through a mix of didactic lectures, interactive tumor boards, case-based discussions, and expert debates, attendees will explore evolving standards of care, new therapeutic strategies, and evidence-based approaches to improve outcomes.
By emphasizing a multidisciplinary approach, the conference fosters collaboration across specialties and includes dedicated opportunities for networking with peers, faculty, and industry partners through exhibits, receptions, and informal exchanges.
The Best of Hematology and Breast Cancer 2027, Boise, is an educational activity planned by Binaytara. Neither Binaytara nor this activity is affiliated with the American Society of Hematology (ASH) or the San Antonio Breast Cancer Symposium (SABCS).
Target Audience
- Medical Oncologists / Hematologists
- Surgical Oncologists
- Radiation Oncologists
- Pathologists
- Oncology Fellows
- Oncology Nurses
- Nurse Practiotioners
- Physician Assistants
- Oncology Pharmacists
Contact Us
Phone: 425-361-0029
Email: sponsorships@binaytara.org
About Binaytara
Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.
As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.
As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.
We invite companies interested in improving equitable access to cancer care to support our efforts.